המוקטין SDH 1000 יחבל
Country: Israel
Language: Hebrew
Source: Ministry of Health
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
HUMAN PLASMA COAGULATION FACTOR VIII
Available from:
KAMADA LTD, ISRAEL
ATC code:
B02BD02
Pharmaceutical form:
אבקה וממס להכנת תמיסה להזרקה
Composition:
HUMAN PLASMA COAGULATION FACTOR VIII 100 IU/ML
Administration route:
תוך-ורידי
Prescription type:
מרשם נדרש
Manufactured by:
BIOTEST PHARMA GMBH, GERMANY
Therapeutic group:
COAGULATION FACTOR VIII
Therapeutic area:
COAGULATION FACTOR VIII
Therapeutic indications:
Treatment and prophylaxis of bleeding: in patients with haemophilia A (congenital factor VIII deficiency) in patient with acquired factor VIII deficiency.Haemoctin is not effective in controlling the bleeding of patients with Von Willebrond`s disease.
Authorization date:
2021-09-30
